New ablation technique tested against standard in heart failure patients
NCT ID NCT07181291
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of ablation (pulsed-field vs cryoballoon) for treating atrial fibrillation in people with heart failure and reduced pumping function. Researchers looked back at 700 patients who had their first ablation to see which method works better and is safer. The goal is to find out if the newer pulsed-field method is as good as the standard cryoballoon method.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pulmonary vein isolation (PVI) procedure
What this could lead to
If successful, this could show that pulsed-field ablation is as safe and effective as cryoballoon ablation for controlling atrial fibrillation in heart failure patients.
What could go wrong
This is a retrospective study, not a randomized trial, so results may be biased. The non-inferiority margin is wide, and the study may not prove one method is better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Evangelisches Krankenhaus Düsseldorf
Düsseldorf, Germany
-
Evangelisches Krankenhaus Hagen-Haspe
Hagen, Germany
-
Kerckhoff-Klinik Bad Nauheim
Bad Nauheim, Germany
-
Klinikum Fürth
Fürth, Germany
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Montreal Heart Institute
Montreal, Quebec, Canada
-
St. Josefs-Hospital Wiesbaden
Wiesbaden, Germany
-
Universitätsklinikum Frankfurt am Main
Frankfurt am Main, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg-Eppendorf, Germany
-
Universitätsklinikum Heidelberg
Heidelberg, Germany
-
Vancouver General Hospital
Vancouver, British Columbia, Canada
-
Vivantes Klinikum am Urban
Berlin, Germany